Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Michelle Renee Griffin currently holds 15,625 shares of Adaptive Biotechnologies Corp (ADPT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michelle Renee Griffin has been a net seller of ADPT stock. They have purchased $0 and sold $4.4M worth of shares.
Michelle Renee Griffin's most recent insider trade was on Mar 11, 2026, when they sold 15,394 shares at $13.91 per share.
Michelle Renee Griffin serves as Executive at Adaptive Biotechnologies Corp (ADPT). They have executed 46 insider transactions totaling $4.4M over their tenure at the company.
Michelle Renee Griffin holds the position of Executive at Adaptive Biotechnologies Corp, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Michelle Renee Griffin has shown a selling trading pattern, with $0 in total purchases and $4.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Michelle Renee Griffin was on Mar 3, 2026, when they sold $735.1K worth of ADPT shares. This transaction involved 48,044 shares at $15.30 per share.
Michelle Renee Griffin currently owns 15,625 shares of Adaptive Biotechnologies Corp (ADPT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Michelle Renee Griffin's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Michelle Renee Griffin has 46 Form 4 filings on record as an insider at Adaptive Biotechnologies Corp.
Set alerts for Michelle Renee Griffin and 40,000+ other insiders.